These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 31327862)

  • 21. Postnatal treatment for children with fetal and neonatal alloimmune thrombocytopenia: a multicentre, retrospective, cohort study.
    de Vos TW; Winkelhorst D; Árnadóttir V; van der Bom JG; Canals Surís C; Caram-Deelder C; Deschmann E; Haysom HE; Hverven HBC; Lozar Krivec J; McQuilten ZK; Muñiz-Diaz E; Nogués N; Oepkes D; Porcelijn L; van der Schoot CE; Saxonhouse M; Sola-Visner M; Tiblad E; Tiller H; Wood EM; Young V; Železnik M; de Haas M; Lopriore E
    Lancet Haematol; 2022 Nov; 9(11):e844-e853. PubMed ID: 36108655
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antiendothelial αvβ3 Antibodies Are a Major Cause of Intracranial Bleeding in Fetal/Neonatal Alloimmune Thrombocytopenia.
    Santoso S; Wihadmadyatami H; Bakchoul T; Werth S; Al-Fakhri N; Bein G; Kiefel V; Zhu J; Newman PJ; Bayat B; Sachs UJ
    Arterioscler Thromb Vasc Biol; 2016 Aug; 36(8):1517-24. PubMed ID: 27283740
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neonatal Thrombocytopenia: Differing Characteristics of NAIT Versus Non-NAIT.
    Zemer VS; Mousa K; Herscovici T; Steinberg-Shemer O; Bonstein L; Yacobovich J
    J Pediatr Hematol Oncol; 2023 Aug; 45(6):e728-e732. PubMed ID: 37027241
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A review of pathophysiology and current treatment for neonatal alloimmune thrombocytopenia (NAIT) and introducing the Australian NAIT registry.
    McQuilten ZK; Wood EM; Savoia H; Cole S
    Aust N Z J Obstet Gynaecol; 2011 Jun; 51(3):191-8. PubMed ID: 21631435
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Maternal HPA-1a antibody level and its role in predicting the severity of Fetal/Neonatal Alloimmune Thrombocytopenia: a systematic review.
    Kjaer M; Bertrand G; Bakchoul T; Massey E; Baker JM; Lieberman L; Tanael S; Greinacher A; Murphy MF; Arnold DM; Baidya S; Bussel J; Hume H; Kaplan C; Oepkes D; Ryan G; Savoia H; Shehata N; Kjeldsen-Kragh J;
    Vox Sang; 2019 Jan; 114(1):79-94. PubMed ID: 30565711
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Timely diagnosis and treatment of neonatal alloimmune thrombocytopenia caused by anti HPA-3a antibody: A case report.
    Yang Q; Lv X; Kong Y; Liu X; Shao M; Zhao Y; Xia N; Wang S; Li H
    Medicine (Baltimore); 2019 May; 98(19):e15440. PubMed ID: 31083173
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Fetal alloimmune thrombocytopenia in pregnant woman with anti-HPA-1a antibodies].
    Sobíšková K; Matěcha J
    Ceska Gynekol; 2016; 81(4):300-303. PubMed ID: 27882754
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Low-avidity anti-HPA-1a alloantibodies are capable of antigen-positive platelet destruction in the NOD/SCID mouse model of alloimmune thrombocytopenia.
    Bakchoul T; Kubiak S; Krautwurst A; Roderfeld M; Siebert HC; Bein G; Sachs UJ; Santoso S
    Transfusion; 2011 Nov; 51(11):2455-61. PubMed ID: 21564107
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A screening and intervention program aimed to reduce mortality and serious morbidity associated with severe neonatal alloimmune thrombocytopenia.
    Kjeldsen-Kragh J; Killie MK; Tomter G; Golebiowska E; Randen I; Hauge R; Aune B; Øian P; Dahl LB; Pirhonen J; Lindeman R; Husby H; Haugen G; Grønn M; Skogen B; Husebekk A
    Blood; 2007 Aug; 110(3):833-9. PubMed ID: 17429009
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neonatal alloimmune thrombocytopenia with significant HLA antibodies.
    Grainger JD; Morrell G; Yates J; Deleacy D
    Arch Dis Child Fetal Neonatal Ed; 2002 May; 86(3):F200-1. PubMed ID: 11978754
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Retrospective comparison of maternal vs. HPA-matched donor platelets for treatment of fetal alloimmune thrombocytopenia.
    Giers G; Wenzel F; Fischer J; Stockschläder M; Riethmacher R; Lorenz H; Tutschek B
    Vox Sang; 2010 Apr; 98(3 Pt 2):423-30. PubMed ID: 19874573
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Developing recombinant HPA-1a-specific antibodies with abrogated Fcgamma receptor binding for the treatment of fetomaternal alloimmune thrombocytopenia.
    Ghevaert C; Wilcox DA; Fang J; Armour KL; Clark MR; Ouwehand WH; Williamson LM
    J Clin Invest; 2008 Aug; 118(8):2929-38. PubMed ID: 18654666
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Management of infants born with severe neonatal alloimmune thrombocytopenia: the role of platelet transfusions and intravenous immunoglobulin.
    Bakchoul T; Bassler D; Heckmann M; Thiele T; Kiefel V; Gross I; Arnold DM; DiTomasso J; Smith JW; Paes B; Greinacher A
    Transfusion; 2014 Mar; 54(3):640-5. PubMed ID: 23869512
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Direct comparison between two quantitative assays in the measurement of maternal anti-HPA-1a antibody in neonatal alloimmune thrombocytopenia (NAIT).
    Bessos H; Killie MK; Matviyenko M; Husebekk A; Urbaniak SJ
    Transfus Apher Sci; 2008 Dec; 39(3):221-7. PubMed ID: 18945639
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Severe intracranial haemorrhage in neonatal alloimmune thrombocytopenia.
    Silva F; Morais S; Sevivas T; Veiga R; Salvado R; Taborda A
    BMJ Case Rep; 2011 Sep; 2011():. PubMed ID: 22679192
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The development of severe neonatal alloimmune thrombocytopenia due to anti-HPA-1a antibodies is correlated to maternal ABO genotypes.
    Ahlen MT; Husebekk A; Killie MK; Kjeldsen-Kragh J; Olsson ML; Skogen B
    Clin Dev Immunol; 2012; 2012():156867. PubMed ID: 22110529
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fetal and neonatal alloimmune thrombocytopenia: progress and ongoing debates.
    Bussel JB; Primiani A
    Blood Rev; 2008 Jan; 22(1):33-52. PubMed ID: 17981381
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Maternal alloimmune antibodies against HPA and HLA class I antigens are associated with reduced birthweight among healthy neonates delivered by Chinese women.
    Xue Y; Xin W; Li C; Zeng X; Song Z; Cao C; Zhao T
    Acta Obstet Gynecol Scand; 2022 Nov; 101(11):1215-1219. PubMed ID: 35871773
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Neonatal alloimmune thrombocytopenia].
    Ohto H
    Nihon Rinsho; 1997 Sep; 55(9):2310-4. PubMed ID: 9301295
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Recurrent HLA-B56 mediated neonatal alloimmune thrombocytopenia with fatal outcomes.
    Hutchinson AL; Dennington PM; Holdsworth R; Downe L
    Transfus Apher Sci; 2015 Jun; 52(3):311-3. PubMed ID: 25634791
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.